Asarfi Hospital Limited has submitted the transcript of its Q2 & H1 FY26 earnings conference call. The company reported H1 FY26 revenue of Rs. 80.6 crores, a 50% year-on-year increase. EBITDA grew 38% to Rs. 15.86 crores, with PAT rising 70% to Rs. 7.32 crores. Operational highlights include 64% occupancy at the Super-speciality Hospital and 44% at the Cancer Hospital, with strong ARPOB growth. The company aims for 500 beds by FY27, targeting Rs. 200+ crores revenue and 13-15% PAT margin, alongside plans to launch a Bone Marrow Transplant Unit and potential mergers.